Carisma Therapeutics, Inc.

Carisma Therapeutics, Inc.verified

CARM

Price:

$0.049

Market Cap:

$2.05M

Carisma Therapeutics, Inc., a biopharmaceutical company, develops chimeric antigen receptors (CAR) macrophages for the treatment of solid tumors. Its solutions are used to play a crucial role in the innate and adaptive immune response, and technology leverages advances in macrophage biology, chimeric antigen receptor engineering, and adoptive cellular therapy for the treatment of human diseases. Carisma Therapeutics, Inc. has a strategic collaboration agreement with Moderna Inc. Carisma Therapeutics, Inc. was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. The company was incorporated in 2016 and is based in Philadelphia, Pennsylvania...[Read more]

Industry

Biotechnology

IPO Date

2014-02-06

Stock Exchange

NASDAQ

Ticker

CARM

The ROE as of December 2025 (TTM) for Carisma Therapeutics, Inc. (CARM) is 162.29%

According to Carisma Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 162.29%. This represents a change of 189.97% compared to the average of 55.97% of the last 4 quarters.

Carisma Therapeutics, Inc. (CARM) Historical ROE (quarterly & annually)

How has CARM ROE performed in the past?

The mean historical ROE of Carisma Therapeutics, Inc. over the last ten years is -42.27%. The current 162.29% ROE has changed -483.93% with respect to the historical average. Over the past ten years (40 quarters), CARM's ROE was at its highest in in the June 2020 quarter at 1.00%. The ROE was at its lowest in in the June 2024 quarter at -3100.56%.

Quarterly (TTM)
Annual

Average

-42.27%

Median

-77.75%

Minimum

-350.71%

Maximum

402.62%

Carisma Therapeutics, Inc. (CARM) ROE by Quarter and Year

Discovering the peaks and valleys of Carisma Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 342.35%

Maximum Annual ROE = 402.62%

Minimum Annual Increase = -3392.31%

Minimum Annual ROE = -350.71%

Quarterly (TTM)
Annual
YearROEChange
2024216.69%-166.18%
2023-327.45%-363.44%
2022124.30%-135.44%
2021-350.71%342.35%
2020-79.28%-119.69%
2019402.62%-628.26%
2018-76.22%-52.65%
2017-160.97%-3392.31%
20164.89%-102.77%
2015-176.58%88.31%

Carisma Therapeutics, Inc. (CARM) Average ROE

How has CARM ROE performed in the past?

The current ROE of Carisma Therapeutics, Inc. (CARM) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

4.51%

5-year avg

-83.29%

10-year avg

-42.27%

Carisma Therapeutics, Inc. (CARM) ROE vs. Peers

How is CARM’s ROE compared to its peers?

Carisma Therapeutics, Inc.’s ROE is greater than Jasper Therapeutics, Inc. (-121.65%), greater than Onconetix, Inc. (-839.59%), greater than Enveric Biosciences, Inc. (-341.49%), greater than SciSparc Ltd. (-83.38%), less than Silexion Therapeutics Ltd. (1.22%), greater than Salarius Pharmaceuticals, Inc. (-401.03%), greater than Revelation Biosciences, Inc. (-194.47%), greater than CDT Equity Inc. (-2194.54%), greater than Indaptus Therapeutics, Inc. (-612.63%), less than Aspire Biopharma Holdings, Inc. (388.20%),

Build a custom stock screener for Carisma Therapeutics, Inc. (CARM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Carisma Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Carisma Therapeutics, Inc. (CARM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Carisma Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Carisma Therapeutics, Inc.'s ROE?

How is the ROE calculated for Carisma Therapeutics, Inc. (CARM)?

What is the highest ROE for Carisma Therapeutics, Inc. (CARM)?

What is the 3-year average ROE for Carisma Therapeutics, Inc. (CARM)?

What is the 5-year average ROE for Carisma Therapeutics, Inc. (CARM)?

How does the current ROE for Carisma Therapeutics, Inc. (CARM) compare to its historical average?